E. Haukaas

发表

A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

U. Vogel, A. Tjønneland, A. Vangsted, 2012, British journal of haematology.

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

H. Nahi, A. Waage, M. Hansson, 2020 .